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The L6 region of bovine adenovirus type (BAdV)-3 encodes a nonstructural protein named 33K. To identify and characterize the 33K
protein, rabbit polyclonal antiserum was raised against a 33K-GST fusion protein expressed in bacteria. Anti-33K serum immunoprecipitated
a protein of 42 kDa in in vitro translated and transcribed mRNA of 33K. However, three proteins of 42, 38, and 33 kDa were detected in
BAdV-3 infected cells. To determine the role of this protein in virus replication, a recombinant BAV-33S1 containing insertional inactivation
of 33K (a stop codon created at the seventh amino acid of 33K ORF) was constructed. Although BAV-33S1 could be isolated, the mutant
showed a severe defect in the production of progeny virus. Inactivation of the 33K gene showed no effect on early and late viral gene
expression in cells infected with BAV-33S1. However, formation of mature virions was significantly reduced in cells infected with BAV-
33S1. Surprisingly, insertional inactivation of 33K at amino acid 97 (pFBAV-33.KS2) proved lethal for virus production. Although
expression of early or late genes was not affected, no capsid formation could be observed in mutant DNA-transfected cells. These results
suggest that 33K is required for capsid assembly and efficient DNA capsid interaction.
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The adenovirus genomes are organized into complex
transcriptional units, which can be generally divided into
early, intermediate, and late regions. The early and inter-
mediate transcription units are expressed before the onset of
viral DNA replication. However, expression of the late
transcription units is dependent on the initiation of viral
DNA replication and depends on the expression of the
major late transcription unit (MLTU), which is controlled
by the major late promoter (MLP) (Thomas and Mathews,
1980). In human adenovirus (HAdV)-5, the MLTU gene-
rates a primary transcript that is processed into more than 20
different cytoplasmic mRNAs, which are divided into five
(L1–L5) families (Frasar et al., 1982). Late transcriptional
units encode structural and nonstructural proteins, which are
involved in the formation of progeny virions.0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: Tikoo@Sask.Usask.Ca (S.K. Tikoo).Bovine adenovirus (BAdV)-3, a member of subgroup I
of BAdVs, has been shown to replicate in cattle producing
mild or no clinical symptoms (Lehmkuhl et al., 1975). Due
to its lack of virulence, BAdV-3 is being developed as a
potential vector for animal vaccines (Baxi et al., 2001;
Zakhartchouk et al., 1999) and for human gene delivery
(Rasmussen et al., 1999). Recently, the complete DNA
sequence of the BAdV-3 genome was determined (Reddy
et al., 1998). In addition, transcriptional maps of E1, E3,
E4, and late regions have been established (Baxi et al.,
1999; Idamakanti et al., 1999; Reddy et al., 1999b). Like
HAdV-5 (Thomas and Mathews, 1980), the BAdV-3 ge-
nome is organized into early, intermediate, and late regions
(Reddy et al., 1998). Unlike HAdV-5 (Berk and Sharp,
1978), the late region of BAdV-3 genome is organized into
seven regions, L1–L7 (Reddy et al., 1998).
The L4 region of the late transcription unit of HAdV-5
encodes two proteins designated 100K and 33K (Oosterom-
Dragon and Anderson, 1983). The 100K protein binds to
newly synthesized hexon monomers and transports to the
nucleus leading to the formation of hexon trimers (Cepko
and Sharp, 1983). The 100K protein also plays a critical role
in the scaffolding process during virus capsid assembly
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allows preferential translation of viral late mRNAs by
binding to RNAs (Hayes et al., 1990). However, little is
known about the 33K protein. The 33K protein is expressed
as a 39K phosphoprotein, which is predominantly localized
to the nuclei of the infected cells (Gambke and Deppert,
1981; Oosterom-Dragon and Anderson, 1983). Like E1A
(Smart et al., 1981), the 33K transcript is internally spliced
and contains a 202-bp intron (Oosterom-Dragon and Ander-
son, 1983). Analysis of a 33K mutant containing a termi-
nation codon introduced in place of amino acid 20 indicated
that 33K is not essential for the replication of HAdV-5
(Fessler and Young, 1999). However, the 33K mutant
showed a sevenfold decrease in the yield of infectious
HAdV-5 (Fessler and Young, 1999). This reduced yield
was suggested to be due to the defect in viral assembly.
Surprisingly, no viable 33K mutant could be isolated when
HAdV-5 33K ORF was truncated by introducing a termi-
nation codon in place of amino acid 184 (Finnen et al.,
2001). The lethal phenotype of the mutant was proposed to
be due to the block in the infectious cycle during the
assembly of progeny virions.
Although 33K ORFs differ considerably, most adenovi-
ruses contain a homolog of the 33K ORF usually over-
lapping the C-terminus of the 100K protein (Vrati et al.,
1995). This suggests that this protein may have an important
function in adenoviral life cycle. The L6 region of the late
transcription unit of BAdV-3 encodes 33K protein (Reddy
et al., 1998). The 33K ORF is predicted to code for a protein
of 274 amino acids (Reddy et al., 1998). Because the 33K
protein of BAdV-3 does not show any homology to the
corresponding proteins of other adenoviruses (Reddy et al.,
1998), we sought to analyze this protein in detail. Here, we
report the characterization of the protein encoded by the
33K ORF. In addition, we describe the construction and
analysis of BAdV-3 mutants carrying insertional inactiva-
tion of 33K gene.Fig. 1. Analysis of 33K protein. (A) Immunoprecipitation of proteins synthesiz
transcribed, and translated pSP64-33K (lanes 1,2,3) and pSP64-33KS1 (lanes 4,5,
(lanes 2,5) or anti-33K (lanes 3, 6) serum were separated on 10% SDS-PAGE gel
markers is shown to the left of the panel. (B, C) Western blot analysis of 33K pr
(lane 1) or wild-type BAdV-3 (lane 2) infected MDBK cells harvested at 48 h po
infected MDBK cells harvested at 12 h (lane 2), 24 h (lane 3), 36 h (lane 4), a
reducing conditions and transferred to nitrocellulose. The separated proteins were
(in kDa) markers is shown to the left of panel. The molecular weight (in kDa) oResults
Characterization of BAdV-3 33K protein
In order to identify and characterize the 33K protein,
anti-GST 33K-fusion serum was produced by immunizing
rabbits with 500 Ag of affinity purified glutathione-S-trans-
ferase (GST)–protein fusions. Sera collected after the final
boost was analyzed by in vitro transcription and translation
to determine the specificity of antibodies in rabbit sera. For
this, the plasmids pSP64-33K and pSP64-33KS1 (33K gene
containing S1 stop codon) were constructed by placing the
coding sequence of the 33K gene and 33KS1 gene down-
stream of the SP6 promoter in pSP64polyA plasmid. In vitro
translation of pSP64-33K RNA resulted in the synthesis of a
polypeptide of 42 kDa (Fig. 1A, lane 1), which was
recognized by anti-33K serum (Fig. 1A, lane 3) but not
by pre-immune sera (Fig. 1A, lane 2). In addition, no such
protein could be detected following in vitro translation of
pSP64-33KS1 RNAwith (Fig. 1A, lanes 5 and 6) or without
(Fig. 1A, lane 4) immunoprecipitation with prebleed (lane 5)
or anti-33K (lane 6) serum.
To further characterize the 33K protein and to confirm the
specificity of the antisera, a Western blot assay was per-
formed. Anti-33K serum detected a major protein of 42 kDa
and two minor proteins of 38 and 33 kDa in BAdV-3 infected
Madin Darby bovine kidney (MDBK) cells (Fig. 1B, lane 2).
No such protein could be detected in mock-infected cells
(Fig. 1B, lane 1). The proteins could be detected at 24–48
h post-infection (Fig. 1C, lanes 3–5) but not at 12 h post-
infection (Fig. 1C, lane 2) or in mock (Fig. 1C, lane 1)-
infected MDBK cells.
Construction of recombinant BAdV-3
Because the amino-terminus of the 33K ORF overlaps the
carboxy terminus of L6 100K ORF (Fig. 2A), point muta-ed by in vitro transcription and translation. [3H]-leucine-labeled, in vitro
6) products before (lanes 1,4) and after immunoprecipitation with prebleed
s under reducing conditions. The position of the molecular weight (in kDa)
otein in wild-type BAdV-3-infected cells. (B) Proteins from mock-infected
st-infection. (C) Protein from mock-infected (lane 1) or wild-type BAdV-3-
nd 48 h (lane 5) post-infection were separated by 10% SDS-PAGE under
probed in Western blots by anti-33K. The position of the molecular weight
f observed proteins is shown to the right of panel.
Fig. 2. L6 region of BAdV-3. (A) Schematic representation of the open reading frames in L6 region. The translation start and stop sites of 100K, 33K, and
pVIII are depicted. The start and stop site of E3 region are also depicted. (B) Sequence of wild-type 33K (33K), insertion of stop codon at amino acid 7 of
33K (33KS1), wild-type 100K (100K), 100K in 33KS1 (100K-A). The changed nucleotide residues in 33KS1/100K-A are shown in bold. The additional
BamHI site created in 33KS1/100K-A is overlined. (C) Sequence of wild-type 33K (33K), insertion of stop codon at amino acid 97 of 33K (33KS2), wild-
type 100K (100K), and 100K in 33KS2 (100K–B). The changed nucleotide residues in 33KS2/100K-B are shown in bold. The additional BamHI site is
overlined.
Fig. 3. Restriction enzyme analysis of recombinant BAdV-3 genomes. The
viral DNAs were extracted from MDBK cells infected with wild-type
BAdV-3 (lane 1), BAV-33S1 (lane 2), BAV-33S1Rev (lane 3), or BAV-
33S2Rev (lane 4) and digested with BamHI. Lane M, 1-kb plus DNA
ladder used for sizing the viral DNA fragments. Sizes of markers are shown
to the left of the panel.
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place of amino acid 7 (S1 stop; Fig. 2B) or amino acid 97 (S2
stop; Fig. 2C). In addition, a BamH1 restriction enzyme
recognition site (Figs. 2B, C) was also created near each of
these stop codons to help initially in identifying the DNA
clones harboring these changes. None of these changes
affected the primary amino acid sequence of L6 100K (Figs.
2B, C). Taking advantage of homologous recombination
machinery of Escherichia coli (Chartier et al., 1996), we
constructed five full-length plasmids: (a) pFBAV-33K.S1,
containing stop codon at amino acid 7 (S1); (b) pFBAV-
33K.S2, containing stop codon at amino acid 97; (c) pFBAV-
33K.S1S2, containing stop codon at amino acid 7 and amino
acid 97; (d) pFBAV-33K.Rev1 containing wild-type 33K;
and (e) pFBAV-33K.Rev2 containing wild-type 33K. The
PacI digested pFBAV-33K.S1, pFBAV-33K.Rev1, and
pFBAV-33K.Rev2 plasmid DNAs, when transfected into
VIDO R2 cells (HAdV-5 E1 transformed fetal bovine retina
cells [FBRCs]; Reddy et al., 1999a), produced cytopathic
effects in 21 days. However, repeated (5 times) transfection
of VIDO R2 or FBRC cells with PacI digested pFBAV-
33K.S2 or pFBAV-33K.S1S2 did not produce cytopathic
effects even after 30 days post-transfection. The transfected
cell monolayers were collected, freeze-thawed, and recom-
binant viruses were plaque purified and propagated in
MDBK cells. The recombinant viruses were named BAV-33S1 (pFBAV-33K.S1), BAV-33S1Rev (pFBAV-33K.Rev1),
and BAV-33S2Rev (pFBAV-33K.Rev2). The presence of the
desired mutation was confirmed by DNA sequence determi-
nation and analysis of restriction enzyme digested recombi-
nant viral DNA using agarose gel electrophoresis. Because
Fig. 4. Analysis of 33K protein in BAV-33S1-infected cells. Monolayers of MDBK cells were mock (C)-infected or infected with wild-type BAdV-3 (A) or
BAV-33S1 (B). At 48 h post-infection, cells were fixed with 100% methanol and visualized by indirect immunostaining with anti-33K serum followed by Cy-
2conjugated goat anti-rabbit secondary antibody using Zeiss AxioVision IV. (D) Proteins from mock (lane 1), BAV-33S1 (lane 2), or wild-type BAdV-3 (lane
3)-infected MDBK cells harvested at 48 h post-infection were separated by 10% SDS-PAGE under reducing conditions and transferred to nitrocellulose. The
separated proteins were probed in Western blots by anti-33K. The position of the molecular weight (in kDa) markers is shown to the left of the panel. The
molecular weight (in kDa) of observed proteins is shown to the right of the panel.
Fig. 5. Virus titers. Near confluent monolayers of MDBK cells were
infected with mutant or wild-type BAdV-3. At different times post-
infection, the cell pellets were freeze-thawed and virus was titrated on
MDBK cells as described in the text. Wild-type BAdV-3 (*), BAV-33S1
(n), BAV-33S1Rev (w ), BAV-33S2Rev (q).
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33K ORF, the viral DNAwas subjected to BamHI digestion.
As seen in Fig. 3, the wild-type BAdV-3 had a fragment of 6
kb (lane 1) that was missing in BAV-33S1, which instead had
fragments of 4.5 kb and 1.5 kb (lane 2). As expected, the
BamHI restriction enzyme digestion patterns of wild-type
BAdV-3 (Fig. 3, lane 1), BAV-33S1Rev (Fig. 3, lane 3), and
BAV-33S2Rev (Fig. 3, lane 4) viral DNAs were similar.
Detection of 33K-specific protein in mutant virus-infected
cells
Initially, expression of the 33K protein in BAV-33S1-
infected MDBK cells was examined by immunofluo-
rescence. As seen in Fig. 4, anti-33K serum detected
protein in the nucleus of the cells infected with wild-type
BAdV-3 (panel A) or BAV-33S1 (panel B). No such
protein could be detected in mock (panel C) infected
cells. The ability of BAV-33S1 to produce 33K protein
was then tested by Western blot analysis of lysates of
virus-infected MDBK cells using anti-33K serum. As
seen in Fig. 4D, anti-33K serum detected three proteins
of 42, 38, and 33 kDa in wild-type BAdV-3-infected cells
(lane 3). However, anti-33K serum detected only 33 kDa
protein in BAV-33S1-infected MDBK cells (lane 2). No
such protein could be detected in mock-infected MDBK
cells (lane 1).Growth kinetics of viruses
In order to determine the role of the 33K protein in
viral replication, the ability of BAV-33S1 to grow in
MDBK cells was compared to that of wild-type BAdV-3.
Virus-infected cells were harvested at different times post-
infection, freeze-thawed three times, and the cell lysates
Fig. 6. Analysis of gene expression in BAV-33S1-infected cells. Proteins from wild-type BAdV-3 (lane 1) or BAV-33S1 (lane 2)-infected MDBK cells were
separated by 10% SDS-PAGE under reducing conditions and transferred to nitrocellulose. The separated proteins were probed in Western blots by anti-E1Bsmall
(A), anti-DBP (B), anti-penton (C), and anti-fiber (D). The position of the molecular weight (in kDa) markers is shown to the left of each panel. The molecular
weight (in kDa) of observed proteins is shown to the right of each panel.
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BAdV-3 grew to a titer of 2  108 TCID50/ml in MDBK
cells. In contrast, BAV-33S1 grew to a titer of 2  104
TCID50/ml, which was slightly higher than the amount of
input virus (Fig. 5). To demonstrate that this impaired
virus growth is indeed due to a defect in 33K, growth
characteristics of BAV-33S1Rev were analyzed. As seen in
Fig. 5, BAV-33S1Rev virus grew to a titer similar to that
of wild-type BAdV-3.
Analysis of gene expression in mutant virus-infected cells
The effect of 33K gene on early (E1Bsmall, DBP) and
late protein (penton, fiber) synthesis was analyzed by
Western blot analysis. MDBK cells infected with BAV-Fig. 7. Indirect immunofluorescence. Confluent monolayers of MDBK cells wer
infection or 96 h post-transfection, the cells were fixed with 100% methanol. Cell
antibody followed by Cy-2conjugated goat anti-rabbit secondary antibody using33S1 or wild-type BAdV-3 were harvested at 12 or 36
h post-infection. Cell lysates were separated by 10%
sodium dodecyl sulfate (SDS)-polyacrylamide gel elec-
trophoresis (PAGE), transferred to nitrocellulose mem-
branes, and probed with protein-specific antiserum. As
seen in Fig. 6, anti-E1Bsmall serum (Fig. 6A, lanes 1 and
2), anti-DBP serum (Fig. 6B, lanes 1 and 2), anti-penton
serum (Fig. 6C, lanes 1 and 2), and anti-fiber serum
(Fig. 6D, lanes 1 and 2) detected proteins of expected
molecular weights, both in wild-type BAdV-3 (lane 1)-
or BAV-33S1 (lane 2)-infected cells. Densitometer anal-
ysis of protein production suggested no significant differ-
ences in the amount of early or late viral proteins
synthesis in BAV-33S1 or wild-type BAdV-3-infected
cells.e infected with BAdV-3 or transfected with mutant DNAs. At 48 h post-
s were visualized by indirect immunostaining with protein-specific primary
Zeiss AxioVision image viewer.
Fig. 8. Production of virus particles in cells infected with wild-type BAdV-3
or BAV-33S1. Crude lysates prepared from cells infected with BAV-33S1 or
wild-type BAdV-3 were separated by centrifugation through continuous
CsCl gradients as described in text. The position of the empty capsids and
mature virions is indicated.
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To determine if early and late genes were expressed in
mutant DNA, VIDO R2 cells were transfected with PacI
digested pFBAV-33K.S1, pFBAV-33K.S2, or pFBAV-
33K.S1S2 DNA and analyzed by indirect immunofluores-
cence using protein-specific antiserum (Fig. 7). Anti-DBP
detected protein in the nucleus of the cells transfected with
mutant DNA or infected with wild-type BAdV-3. In some
cells, punctuate nuclear staining was also observed. Anti-
hexon serum detected protein predominantly in the cyto-
plasm of cells transfected with mutant DNA or in cytoplasm
and nucleus of the cells infected with wild-type BAdV-3.
Anti-fiber serum detected protein predominantly in the
nucleus of cells infected with wild-type BAdV-3. In con-
trast, anti-fiber serum detected protein predominantly in the
cytoplasm of the mutant DNA-transfected cells. It is possi-Fig. 9. Electron microscopic analysis of virus-infected cells. Mock-infected (A), w
shown.ble that interaction of 33K with hexon/fiber is required for
transport of these proteins to the nucleus.
Analysis of capsid assembly
Viral capsid assembly was analyzed in MDBK cells
infected with BAV-33S1 or wild-type BAdV-3. Cells were
harvested, freeze-thawed, and resolved on preformed CsCl
gradients ranging in the density from 1.35 to 1.25 g/cm3 to
separate mature virions from less dense empty particles. As
seen in Fig. 8, both types of particles were present in the
lysates of cells infected with BAV-33S1 or wild-type BAdV-
3. However, the amount of mature virions present in BAV-
33S1-infected cell lysates was significantly lower than the
amount detected in wild-type BAdV-3-infected cell lysates.
To further check for capsid formation, transmission
electron microscopy was performed on the MDBK cells
infected with BAV-33S1 or wild-type BAdV-3. The
infected cells were harvested at different time points and
examined by electron microscopy (Fig. 9). Capsid forma-
tion appeared to be normal in BAV-33S1 (Fig. 9B) and in
wild-type BAdV-3 (Fig. 9C)-infected cells. However, un-
like the capsids seen in wild-type BAdV-3-infected cells
(Fig. 9C), most of which contained a darkly staining core,
many of the capsids in BAV-33S1 (Fig. 9B) infected
MDBK cells were lightly staining suggesting that they
lacked core components.
Detection of 33K in empty/mature capsids
In order to determine if the 33K protein is part of the
empty/mature capsids, Western blot analysis was per-
formed. As seen in Fig. 10, anti-fiber serum (panel B),
anti-penton serum (panel C), and anti-hexon serum (panel
D) detected proteins of similar molecular weight in empty
capsids of BAV-33S1 (lane 1) or wild-type BAdV-3 (lane
2). However, although anti-33K serum detected a protein
of 42 kDa protein in empty capsids of wild-type BAdV-3
(Fig. 10A, lane 2), anti-33K serum detected a protein ofild-type BAdV-3-infected (C), or BAV-33S1-infected (B) MDBK cells are
Fig. 10. Analysis of empty capsid proteins. Samples of CsCl purified empty capsids of BAV-33S1 (lane 1,3) or wild-type BAdV-3 (lane 2,4) were boiled in
Laemmli loading sample buffer and separated by 10% SDS-PAGE under reducing conditions. Electrophoretically resolved viral proteins were transferred to
nitrocellulose and probed in Western blot by anti-33K (A), anti-fiber (B), anti-penton (C), and anti-hexon (D). The molecular weight (in kDa) of observed
proteins is shown to the right of each panel.
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Although fiber (Fig. 10B), penton (Fig. 10C), and hexon
(Fig. 10D) proteins could be detected in mature virions
of both BAV-33KS1 (lane 3) and wild-type BAdV-3 (lane
4), no 33K protein could be detected in mature virions of
BAV-33KS1 (Fig. 10A, lane 3) or wild-type BAdV-3
(Fig. 10A, lane 4).Discussion
Because most adenoviruses contain a homolog of the
33K ORF, usually overlapping the C-terminus of the 100K
protein (Vrati et al., 1995), it is believed that this protein
may have an important function(s) in adenoviral life cycle.
Recent reports indicate that the 33K protein may be
involved in the assembly of progeny virions (Fessler and
Young, 1999; Finnen et al., 2001). However, the stage in
the assembly pathway of HAdV-5 at which 33K is required
is not known. In addition, whether 33K is absolutely
required for HAdV-5 replication is not clear (Finnen et al.,
2001). Although BAdV-3 33K ORF is collinear with the
33K gene of other adenoviruses, it does not show any
homology with most of its counterparts (Reddy et al.,
1998). The present study was performed to characterize
the 33K protein and determine the function of 33K protein
in BAdV-3 replication.
The 33K mRNA of BAdV-3 is predicted to encode a
protein of 274 amino acids (Reddy et al., 1998). However,
three proteins of 42, 38, and 33 kDa could be detected in
BAdV-3-infected MDBK cells. It is possible that three
forms of 33K proteins are translated from different ATG
codons (Reddy et al., 1998). Alternatively, different formsof 33K protein arise by alternate splicing. The apparent
molecular mass of the proteins produced in BAdV-3-
infected cells does not fit well with the calculated mass
(30 kDa) of the 33K ORF (274 amino acids). This may be
due to high number of proline and glutamine residues.
Similar observations have been reported for the 33K
protein of HAdV-5 (Egan et al., 1988; Yee and Branton,
1985). The 33K protein is localized predominantly in the
nucleus of BAdV-3-infected cells. The 33K protein is not
detected in mature BAdV-3 virions, but is present in the
empty capsids suggesting that 33K may function as a
scaffolding protein.
Although mutant BAV-33S1 virus containing a stop
codon at amino acid 7 could be isolated in FBRC and
VIDOR2 cells, the mutant virus showed a severe defect in
the production of progeny virus. In contrast, mutant BAV-
33S2 virus containing a stop codon at amino acid 97 could
not be isolated. These phenotypes could be attributed to the
introduced mutations as revertant viruses could be isolated,
which displayed growth characteristics of wild-type BAdV-
3. The block in the production of progeny BAV-33S1 virus
could not be due to the defect in viral protein synthesis as
both BAV-33S1 and wild-type BAdV-3 produced similar
amounts of early and late viral proteins in infected cells. In
addition, despite the block in the production of progeny
(BAV-33S2) virus, both early and late viral protein synthe-
sis could also be detected in the cells transfected with either
pFBAV-33K.S2 or pFBAV-33K.S1S2 DNAs. Taken togeth-
er, these results suggest that 33K is required in the assembly
of progeny virions. These results are consistent with earlier
observations that the 33K protein may be required for the
assembly of HAdV-5 virions (Fessler and Young, 1999;
Finnen et al., 2001).
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infected cell nuclei stained positive with anti-33K serum.
However, Western blot analysis did not detect a 42 kDa
protein in BAV-33S1-infected cells. Instead, only a 33 kDa
protein could be detected in BAV-33S1-infected cells. In
contrast, although early and late protein expression could be
detected in pFBAV-33K.S2 transfected cells, no 33K-spe-
cific protein could be detected in mutant-infected cells. As
BAV-33S2 contains a termination codon at amino acid 97, it
is certain that the 33 kDa protein observed in BAV-33S1-
infected cells lacks at least the N-terminal 97 amino acids of
the mature 33K protein.
Comparison of the polypeptide composition of BAV-
33S1 intermediates with those of wild-type BAdV-3 empty
capsids revealed no major difference except in the molec-
ular weight of 33K. Although wild-type BAdV-3 empty
capsids contained a protein of 42 kDa, BAV-33S1
contained a protein with an apparent molecular weight of
33 kDa. However, no such proteins could be detected in
the mature BAV-33S1 or wild-type BAdV-3 virions. More-
over, truncation of 33K at amino acid 97 blocked forma-
tion of all types of viral particles. These results suggest
that C-terminal (probably amino acids 98–274) part of the
33K protein functions as a scaffolding protein during
capsid assembly. Similar mutation/deletion of scaffolding
protein(s) in other viral systems is associated with com-
plete loss of capsid formation or appearance of aberrant
capsid structures (Casjens and Hendrix, 1988; Desai et al.,
1994).
Analysis of assembly intermediates by electron micros-
copy revealed no significant difference in the formation of
capsids in BAV-33S1 or wild-type BAdV-3-infected cells.
In contrast, comparison to wild-type BAdV-3-infected
cells, the formation of mature virions was significantly
reduced in BAV-33S1-infected cells. Moreover, compari-
son of CsCl gradient purification of virions also indicated
that the amount of mature virions in BAV-33KS1-infected
cell lysates was significantly lower than the amount of
mature virions in wild–type BAdV-3-infected cells. This
suggests that the 33K protein is also involved in interac-
tion between the DNA and capsid/DNA encapsidation.
Although this interaction is not required for isolating
viable BAdV-3, it is required for efficient formation of
mature virions. Because the C-terminus amino acids 98–
274 are presumably represented in the 33 kDa protein
expressed in BAV-33S1-infected cells, this function may
reside in the N-terminus 97 amino acids of the 33K
protein.
Earlier, conflicting observations were reported regarding
the function of HAdV-5 33K protein (Fessler and Young,
1999; Finnen et al., 2001). Although truncation of 33K
protein at 19 amino acids from the N-terminus yielded
viable virus (Fessler and Young, 1999), truncation of 33K
protein 47 amino acids before the C-terminus completely
inhibited virus replication (Finnen et al., 2001). Because
expression of 33K protein(s) was not analyzed in thesestudies, the conflicting conclusions were based on the
assumption that only one form of 33K protein is expressed
in mutant-infected cells. We believe that like BAdV-3, at
least two forms of 33K protein are expressed in the HAdV-5
33K mutants.
Several lines of evidence suggest that the adenoviruses
are assembled by insertion of virion DNA and core proteins
in preformed empty capsids (D’Halluin, 1995; Gustin and
Imperiale, 1998). Recent report has suggested the possibility
that the adenoviruses may assemble by coordinating capsid
formation with DNA encapsidation (Zhang and Imperiale,
2003). Based on our results and proposed models of
assembly, we suggest that the 33K protein of BAdV-3 plays
two distinct roles in adenovirus assembly, namely, (a)
assembly of capsids and (b) efficient association of viral
DNA and capsid/DNA encapsidation. Further work is
required to precisely localize the domains of BAdV-3 33K
protein involved in these functions.Materials and methods
Cell lines and viruses
MDBK, FBRC, and VIDO R2 cells were cultivated in
Eagles minimum essential medium (MEM) supplemented
with 10% fetal bovine serum (FBS). Wild-type and mutant
BAdV-3s were cultivated in MDBK cells (Reddy et al.,
1999b).
Plasmid construction
The plasmid vectors were constructed as per standard
procedures using restriction enzymes and other DNA modi-
fying enzymes (Sambrook and Russell, 2000).
Construction of plasmid pGEX-33K
A 1.2-kb AatII–BamHI fragment containing the 33K
gene excised from plasmid pSM12 (containing the BamHI
‘‘B’’ fragment of BAdV-3 genome in plasmid PUC18) was
blunt end repaired with T4 DNA polymerase and ligated to
SalI digested (blunt end repaired with T4 polymerase)
plasmid pGEX-5X to create plasmid pGEX-33K. This
plasmid contains the coding sequence of the 33K protein
(C-terminus 195 amino acids) fused in frame to the gene
encoding glutathione-S-transferase (GST) in a pGEX vector
(Pharmacia). The junction of the sequence encoding 33K-
GST was sequenced to ensure that the coding domains were
in-frame.
Construction of plasmid p33S1
A 7.6-kb EcoRI fragment of plasmid pSM12 was isolat-
ed and religated to create plasmid pSM12M. A 306-bp
fragment isolated by PCR amplification [using oligonucleo-
tides (1) 5V-GGCACGGAGTGTATCTGGACCCTC
AGACCGGCGAGGAGCTGAACGGACCCGCACC-
V. Kulshreshtha et al. / VirolCTCCGCAGCTAGGAATGAAACCCCGCAGCATGTAG-
GATCCCGGGCCTTCCGCGGC-3V and (2) 5V-CT-
CGACGTCTTCGTCCGTGAAGTCGCTG AA-3V and
plasmid pSM14 (containing BamHI ‘‘D’’ fragment in plas-
mid PUC18, Mittal et al., 1995) as a template] was digested
with DraIII–AatII and ligated to a 7.3-kb DraIII–AatII
digested plasmid pSM12M creating plasmid p33S1.
Construction of plasmid p33S2
A 7.5-kb AatII–PshAI fragment of plasmid pSM12 was
isolated and ligated to 96 bp complimentary oligonucleo-
tides [(1) 5V-CGAGGAGGAGGATATGATTTCGA-
TACCCCGCGACCAGGGGCACTAAGGCGAGCTC-
G A G G A G G G C G A A AT T C C C G C A A C G G A -
TCCGGCGACGG-3V; (2) 5V-CCGTCGCCGGAT
CCGTTGCGGGAATTTCGCCCTCCTCGAGCTCGCCT-
TAGTGCCCCTGGTCGCGGGGTATCGAAATCA-
TATCCTCCTCCTCGACGT-3V] to create plasmid p33S2.
A 7.3-kb DraIII–AatII fragment of p33S2 was isolated and
ligated to a 306-bp DraIII–AatII fragment of p33S1 crea-
ting plasmid p33S1S2.
Construction of plasmids pSP64-33K and pSP64-33KS1M
A 1047-base pair DraIII–BspMII fragment from plasmid
pSM12 (containing wild-type 33K) or plasmid pSM12MS1
(containing mutant 33K) was blunt end repaired by T4 DNA
polymerase and individually ligated to HindIII digested
(blunt end repaired by T4 polymerase) plasmid pSP64
Poly-A (Pharmacia) to create plasmid pSP64-33K (contai-
ning wild-type 33K) and pSP64-33KS1M (containing mu-
tant 33K).
Production of antisera
The production and the characterization of BAdV-3
E1Bsmall (Reddy et al., 1999b), BAdV-3 DNA binding
protein (DBP)(Zhou et al., 2001), and BAdV-3 fiber (Wu
and Tikoo, 2004)-specific antibodies have been described.
The antibodies generated against BAdV-3 hexon, and
BAdV-3 penton recognize a protein of 98 and 62 kDa,
respectively, in BAdV-3-infected cells (Wu and Tikoo,
unpublished data).
To produce BAdV-3 33K-specific antiserum, the plasmid
pGEX-33K was transformed in E. coli strain BL21. The
fusion protein production was induced by the addition of
0.1 M isopropyl-h-thiogalactoside (IPTG) and analyzed by
SDS-PAGE. Finally, the GST-33K fusion protein was affi-
nity purified using GST columns. Briefly, cells were pelleted
and resuspended in 5 ml of PBS. Cells were lysed by
sonication and supernatant was applied to GST columns.
The matrix was washed by PBS and the fusion protein was
eluted in glutathione elution buffer. Rabbits were immu-
nized subcutaneously with affinity purified GST-33K fusion
protein in Freund’s complete adjuvant followed by four
injections in Freund’s incomplete adjuvant at 3 weeks
interval.In vitro transcription/translation and immunoprecipitation
Plasmid DNAs (1–2 Ag) were transcribed in vitro using
SP6 RNA polymerase as described by supplier (Promega).
The transcribed RNAs were translated at 30 jC for 2 h using
rabbit reticulocyte lysate (TNT coupled reticulocyte lysate
systems, Promega) in the presence of 50 Aci [3H]-leucine
(Amersham). The translated proteins were analyzed on
SDS-PAGE with or without immunoprecipitation as des-
cribed earlier (Idamakanti et al., 1999) with the anti-33K
serum.
Construction of full-length recombinant plasmids
Construction of plasmid pFBAV-33K.S1
A 3.1-kb HpaI–SmaI fragment of plasmid pSL301
(Invitrogen) was isolated and religated to create plasmid
pSL301m. A 6.8-kb AvrII fragment of pTG5485 was
isolated and ligated to AvrII-digested plasmid pSL301m to
create plasmid pSL68. A 9.2-kb Eco47III–AscI fragment of
plasmid pSL68 was isolated and ligated to a 768-bp
Eco47III–AscI fragment of pSM12S1 to create plasmid
pSM12S1T. The recombinant BAdV-3 genome containing
33K.S1 (pFBAV-33K.S1) was generated by homologous
recombination in E. coli BJ5183 (Chartier et al., 1996)
between SrfI-digested pFBAV302 (Zakhartchouk et al.,
1998) and a 6.8kb AvrII fragment of plasmid pSM12S1T.
Construction of recombinant plasmid pFBAV-33K.S2
A 9.2-kb MunI–AscI fragment of pSL68 was isolated
and ligated to a 752-bp MunI–AscI fragment of pSM12S2
to create plasmid pSM12S2T. The recombinant BAV-3
genome containing 33K.S2 (pFBAV-33K.S2) was generated
by homologous recombination in E. coli BJ5183 (Chartier
et al., 1996) between SrfI-digested pFBAV302 (Zakhartch-
ouk et al., 1998) and a 6.8-kb AvrII fragment of plasmid
pSM12S2T.
Construction of recombinant plasmid (pFBAV-33K.S1S2)
A 9.2-kbMunI–AscI fragment of pSL68 was isolated and
ligated to a 755-bp MunI–AscI fragment of pSM12S1S2 to
create plasmid pS1S2. The recombinant BAdV-3 genome
containing 33K.S1S2 (pFBAV-33K.S1S2) was generated by
homologous recombination in E. coli BJ5183 (Chartier et al.,
1996) between SrfI-digested pFBAV302 (Zakhartchouk et
al., 1998) and a 6.8-kb AvrII fragment of pS1S2.
Construction of full-length revertant plasmid DNAs
(pFBAV-33Rev1, pFBAV-33Rev2)
The recombinant BAdV-3 genome (pFBAV-33Rev1) was
generated by homologous recombination in E. coli BJ5183
between a 9.9-kb NdeI–EcoRV fragment of pFBAV302 and
a 27.4-kb RsrII–SfiI fragment of pFBAV-33K.S1. The
recombinant BAdV-3 genome (pFBAV-33Rev2) was gene-
rated by homologous recombination in E. coli BJ5183
(Chartier et al., 1996) between a 8-kb AscI–SapI fragment
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Transfection and isolation of BAV-3 mutant viruses
VIDO R2 cell (Reddy et al., 1999a) or FBRC mono-
layers in six-well plates were transfected with 5–7.5 Ag of
PacI-digested recombinant full-length plasmid DNAs
pFBAV-33K.S1, pFBAV-33K.S2 pFBAV-33K.S1S2,
pFBAV-33K.Rev1, or pFBAV-33K.Rev2 using Lipofectin
(Gibco BRL). Following transfection, the cells were main-
tained in MEM containing 3% FBS at 37 jC. After 16
days, the transfected cells showing cytopathic effects were
harvested and freeze-thawed 3 times. Finally, the recom-
binant viruses were plaque purified and expanded in
MDBK cells (Reddy et al., 1999b; Zakhartchouk et al.,
1998).
Virus growth curve
MDBK cells were infected with mutant or wild-type
BAdV-3 at a multiplicity of infection of 5. The infected
MDBK cells harvested at indicated times post-infection
were lysed in the medium by freeze-thawing three times
to release the virus in the medium. The virus titers were
determined by serial dilution infection of MDBK cells and
calculating TCID50.
Western blot analysis
MDBK cells in the six-well plates were infected with
mutant or wild-type BAdV-3 at a multiplicity of infection of
5. Infected cells harvested at indicated times post-infection
were lysed by the addition of 100 Al RIPA buffer (0.15 M
NaCl, 50 mM Tris–HCl, pH 8.0, 1% NP-40, 1% deoxy-
cholate, 0.1% SDS). Proteins from the lysates of infected
cells were analyzed on 10% SDS-PAGE under reducing
conditions and were electrotransferred to nitrocellulose
membranes (Bio-Rad). Nonspecific binding sites on the
membrane were blocked with 1% bovine serum albumin.
The membrane was probed with protein-specific rabbit
polyclonal antisera. The membrane was washed 3 times,
exposed to goat anti-rabbit IgG conjugated to alkaline
phosphatase, and developed using an alkaline phosphatase
color development kit (Bio-Rad).
Immunofluorescence staining
Monolayers of MDBK cells seeded in four-well Lab-Tek
chamber slides were infected with wild-type or mutant
BAdV-3s. At different times post-infection, the infected
cells were fixed with 100% methanol for 15 min at
20 jC. The fixed cells were incubated with protein-
specific primary antibody followed by Cy-2conjugated
goat-anti-rabbit IgG. Finally, the cells were observed under
a fluorescence microscope.CsCl gradient analysis
Monolayers of MDBK cells were infected with mutant
or wild-type BAdV-3 at a multiplicity of infection of 10. At
48 h post-infection, the cells were harvested, resuspended in
0.1 M Tris, pH 8.0, and freeze-thawed 3 times. The cellular
debris was removed by centrifugation and 5 ml of each
lysate was loaded on preformed 1.3–1.2 g/cm3 CsCl
gradient. The gradients were centrifuged at 35000 rpm for
overnight at 4 jC and photographed.
Transmission electron microscopy
Electron microscopy was performed on BAV-33S1 and
wild-type BAdV-3-infected MDBK cells, or mutant DNA-
transfected cells. At 48 h post-infection, the cells were
washed twice with cold MEM without serum and harvested.
The cells were fixed in 3% glutaraldehyde in 0.1 M sodium
cacodylate buffer. The cells were centrifuged and the
supernatant was removed. The pellet was mixed with 2%
agarose and centrifuged again. The agar pieces having
pelleted material were placed in 0.1 M sodium cacodylate
buffer at 4 jC. The pellet was then fixed in 1% OsO4 in
1.25% sodium bicarbonate for 1 h at room temperature and
then dehydrated in a graded ethanol series. The pellet was
given 3–5 min rinses with propylene oxide and then
infiltrated in epon/araldite resin at room temperature. The
pellet was placed in silicone molds and polymerized at
55 jC for 24 h. Finally, the pellet was cut on a Reichert
ultracut E microtome, stained with lead citrate, and viewed
on a Philips 410LS TEM.
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